- Home
- EHC vs RVTY Comparison
EHC vs RVTY Comparison
Compare EHC & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EHC | RVTY |
|---|---|---|
| Founded | 1983 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 9.9B |
| IPO Year | 1986 | N/A |
Fundamental Metrics
Financial Performance| Metric | EHC | RVTY |
|---|---|---|
| Price | $107.50 | $97.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 14 |
| Target Price | ★ $141.88 | $113.46 |
| AVG Volume (30 Days) | 1.0M | ★ 1.2M |
| Earning Date | 02-05-2026 | 01-30-2026 |
| Dividend Yield | ★ 0.70% | 0.29% |
| EPS Growth | ★ 27.89 | N/A |
| EPS | ★ 5.29 | 1.99 |
| Revenue | ★ $5,795,600,000.00 | $2,813,367,000.00 |
| Revenue This Year | $11.54 | $5.33 |
| Revenue Next Year | $8.76 | $3.03 |
| P/E Ratio | ★ $20.41 | $48.76 |
| Revenue Growth | ★ 11.13 | 3.37 |
| 52 Week Low | $87.85 | $81.36 |
| 52 Week High | $127.99 | $128.29 |
Technical Indicators
Market Signals| Indicator | EHC | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 37.01 | 48.85 |
| Support Level | $105.90 | $95.87 |
| Resistance Level | $108.56 | $98.55 |
| Average True Range (ATR) | 1.82 | 2.52 |
| MACD | 0.29 | -0.45 |
| Stochastic Oscillator | 52.96 | 23.56 |
Price Performance
Historical ComparisonAbout EHC Encompass Health Corporation
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
About RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.